Innate Pharma S.A. (IPHA)

Nasdaq: IPHA · Biological Products, (No Diagnostic Substances) · Marseille · filing with the SEC since 2014

Grade4.3

◀ Past 5.9● Present 4.0▶ Future 3.5

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In euros (EUR), as filed; per-share figures in euros; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Report filed	Apr 1, 2026	Apr 30, 2025	Apr 4, 2024	Apr 6, 2023	Apr 4, 2022	Apr 27, 2021	Apr 24, 2020	·	·
Revenue	9,005,000	20,121,000	61,641,000	57,674,000	24,703,000	69,773,000^r	85,449,000^r	93,952,000	44,033,000
Research and development	43,620,000	51,980,000	56,022,000	51,663,000	47,004,000	49,708,000^r	62,897,000^r	69,555,000	67,000,000
Selling, general and administrative	·	19,716,000	18,288,000	22,436,000	25,524,000	18,986,000^r	20,977,000^r	18,142,000	17,015,000
Sales and marketing	519,000	353,000	368,000	660,000	472,000	504,000^r	592,000^r	518,000	649,000
General and administrative	19,394,000	19,716,000	18,288,000	·	·	·	·	18,142,000	·
Total operating expenses	63,013,000	71,696,000	74,310,000	115,099,000	72,528,000	68,694,000^r	83,874,000^r	87,697,000	84,015,000
Operating income	-54,008,000	-51,575,000	-12,669,000	-57,425,000	-47,825,000	1,079,000^r	1,575,000^r	5,146,000	-39,983,000
Finance costs	3,120,000	3,975,000	1,835,000	5,321,000	3,997,000	6,763,000	4,976,000	8,429,000	10,535,000
Finance income	7,951,000	6,079,000	6,934,000	4,775,000	6,344,000	4,855,000	11,269,000	6,002,000	2,501,000
Net finance income (costs)	4,831,000	2,104,000	5,099,000	-546,000	2,347,000	-1,908,000	6,293,000	-2,427,000	-8,034,000
Income before income taxes	-49,177,000	-49,471,000	-7,570,000	-57,972,000	-45,478,000	-829,000^r	7,868,000^r	2,718,000	-48,016,000
Income tax expense	0	0	0	0	0	0	0	-333,000	368,000
Income from continuing operations	-49,177,000	-49,471,000	-7,570,000	-57,972,000	-45,478,000	-829,000	7,868,000	·	·
Income from discontinued operations	·	0	0	-131,000	-7,331,000	-63,155,000	-28,627,000	·	·
Net income	-49,177,000	-49,471,000	-7,570,000	-58,103,000	-52,809,000	-63,984,000	-20,759,000	3,049,000	-48,385,000
Earnings per share, basic	-0.55	-0.61	-0.09	-0.73	-0.66	-0.81	-0.31	0.05	-0.89
Earnings per share, diluted	-0.55	-0.61	-0.09	-0.73	-0.66	-0.81	-0.31	0.05	-0.89
Weighted average shares, basic	89,591,001	81,051,798	80,453,282	79,639,826	79,542,627	78,934,960	66,908,389	58,776,712	54,351,967

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:Revenue

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense

Sales and marketing the cost of finding and serving customersifrs-full:SalesAndMarketingExpense

General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherifrs-full:OperatingExpense

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:FinanceCosts

Finance income what its cash and investments earnedifrs-full:FinanceIncome

Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations

Income from discontinued operations profit or loss from businesses it sold or closedifrs-full:ProfitLossFromDiscontinuedOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

SI Assistanton IPHA · research, not advice